• レポートコード:MRC2012A10336 • 出版社/出版日:GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、109ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医薬品、医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、腸チフスワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。腸チフスワクチンの種類別市場規模(経口タイプ、注射タイプ)、用途別市場規模(病院、研究所、研究所、製薬・バイオテクノロジー企業、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Sanofi、PaxVax、Merck、Bharat Biotec、GlaxoSmithKline、Merit Pharmaceuticals、Actiza Pharmaceutical、 ・地域別グローバル市場分析 2015年-2020年 ・腸チフスワクチンの北米市場(アメリカ、カナダ、メキシコ) ・腸チフスワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア) ・腸チフスワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア) ・腸チフスワクチンの南米市場(ブラジル、アルゼンチン) ・腸チフスワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ) ・種類別分析:経口タイプ、注射タイプ ・用途別分析:病院、研究所、研究所、製薬・バイオテクノロジー企業、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Typhoid Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Typhoid Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Typhoid Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Typhoid Vaccine market has been segmented into
Oral Type
Injection Type
By Application, Typhoid Vaccine has been segmented into:
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Typhoid Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Typhoid Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Typhoid Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Typhoid Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Typhoid Vaccine Market Share Analysis
Typhoid Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Typhoid Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Typhoid Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Typhoid Vaccine are:
Sanofi
PaxVax
Merck
Bharat Biotec
GlaxoSmithKline
Merit Pharmaceuticals
Actiza Pharmaceutical
Among other players domestic and global, Typhoid Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Typhoid Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Typhoid Vaccine, with price, sales, revenue and global market share of Typhoid Vaccine in 2018 and 2019.
Chapter 3, the Typhoid Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Typhoid Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Typhoid Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Typhoid Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Typhoid Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Typhoid Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral Type
1.2.3 Injection Type
1.3 Market Analysis by Application
1.3.1 Overview: Global Typhoid Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Overview of Global Typhoid Vaccine Market
1.4.1 Global Typhoid Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 PaxVax
2.2.1 PaxVax Details
2.2.2 PaxVax Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 PaxVax SWOT Analysis
2.2.4 PaxVax Product and Services
2.2.5 PaxVax Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bharat Biotec
2.4.1 Bharat Biotec Details
2.4.2 Bharat Biotec Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bharat Biotec SWOT Analysis
2.4.4 Bharat Biotec Product and Services
2.4.5 Bharat Biotec Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GlaxoSmithKline SWOT Analysis
2.5.4 GlaxoSmithKline Product and Services
2.5.5 GlaxoSmithKline Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merit Pharmaceuticals
2.6.1 Merit Pharmaceuticals Details
2.6.2 Merit Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merit Pharmaceuticals SWOT Analysis
2.6.4 Merit Pharmaceuticals Product and Services
2.6.5 Merit Pharmaceuticals Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Actiza Pharmaceutical
2.7.1 Actiza Pharmaceutical Details
2.7.2 Actiza Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Actiza Pharmaceutical SWOT Analysis
2.7.4 Actiza Pharmaceutical Product and Services
2.7.5 Actiza Pharmaceutical Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Typhoid Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Typhoid Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Typhoid Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Typhoid Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Typhoid Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Typhoid Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Typhoid Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Typhoid Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Typhoid Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Typhoid Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Typhoid Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Typhoid Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Typhoid Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Typhoid Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Typhoid Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Typhoid Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Typhoid Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Typhoid Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Typhoid Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Typhoid Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Typhoid Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Typhoid Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Typhoid Vaccine Sales and Growth Rate (2015-2020)
6.4 France Typhoid Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Typhoid Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Typhoid Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Typhoid Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Typhoid Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Typhoid Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Typhoid Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Typhoid Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Typhoid Vaccine Sales and Growth Rate (2015-2020)
7.5 India Typhoid Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Typhoid Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Typhoid Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Typhoid Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Typhoid Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Typhoid Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Typhoid Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Typhoid Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Typhoid Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Typhoid Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Typhoid Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Typhoid Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Typhoid Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Typhoid Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Typhoid Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Typhoid Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Typhoid Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Typhoid Vaccine Price by Type (2015-2020)
11 Global Typhoid Vaccine Market Segment by Application
11.1 Global Typhoid Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Typhoid Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Typhoid Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Typhoid Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Typhoid Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Typhoid Vaccine Market Forecast (2021-2025)
12.2.2 Europe Typhoid Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Typhoid Vaccine Market Forecast (2021-2025)
12.2.4 South America Typhoid Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Typhoid Vaccine Market Forecast (2021-2025)
12.3 Typhoid Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Typhoid Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Typhoid Vaccine Market Share Forecast by Type (2021-2025)
12.4 Typhoid Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Typhoid Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Typhoid Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Typhoid Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Typhoid Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Typhoid Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Typhoid Vaccine Major Business
Table 9. Sanofi Typhoid Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Typhoid Vaccine Product and Services
Table 12. Sanofi Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. PaxVax Basic Information, Manufacturing Base and Competitors
Table 14. PaxVax Typhoid Vaccine Major Business
Table 15. PaxVax Typhoid Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. PaxVax SWOT Analysis
Table 17. PaxVax Typhoid Vaccine Product and Services
Table 18. PaxVax Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Typhoid Vaccine Major Business
Table 21. Merck Typhoid Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Merck SWOT Analysis
Table 23. Merck Typhoid Vaccine Product and Services
Table 24. Merck Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bharat Biotec Basic Information, Manufacturing Base and Competitors
Table 26. Bharat Biotec Typhoid Vaccine Major Business
Table 27. Bharat Biotec Typhoid Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Bharat Biotec SWOT Analysis
Table 29. Bharat Biotec Typhoid Vaccine Product and Services
Table 30. Bharat Biotec Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline Typhoid Vaccine Major Business
Table 33. GlaxoSmithKline Typhoid Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. GlaxoSmithKline SWOT Analysis
Table 35. GlaxoSmithKline Typhoid Vaccine Product and Services
Table 36. GlaxoSmithKline Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merit Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 38. Merit Pharmaceuticals Typhoid Vaccine Major Business
Table 39. Merit Pharmaceuticals Typhoid Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Merit Pharmaceuticals SWOT Analysis
Table 41. Merit Pharmaceuticals Typhoid Vaccine Product and Services
Table 42. Merit Pharmaceuticals Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Actiza Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Actiza Pharmaceutical Typhoid Vaccine Major Business
Table 45. Actiza Pharmaceutical Typhoid Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Actiza Pharmaceutical SWOT Analysis
Table 47. Actiza Pharmaceutical Typhoid Vaccine Product and Services
Table 48. Actiza Pharmaceutical Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Typhoid Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Typhoid Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Typhoid Vaccine Sales by Regions (2015-2020) (K Units)
Table 52. Global Typhoid Vaccine Sales Market Share by Regions (2015-2020)
Table 53. Global Typhoid Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Typhoid Vaccine Sales by Countries (2015-2020) (K Units)
Table 55. North America Typhoid Vaccine Sales Market Share by Countries (2015-2020)
Table 56. North America Typhoid Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Typhoid Vaccine Revenue Market Share by Countries (2015-2020)
Table 58. Europe Typhoid Vaccine Sales by Countries (2015-2020) (K Units)
Table 59. Europe Typhoid Vaccine Sales Market Share by Countries (2015-2020)
Table 60. Europe Typhoid Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Typhoid Vaccine Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Typhoid Vaccine Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Typhoid Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Typhoid Vaccine Sales by Countries (2015-2020) (K Units)
Table 65. South America Typhoid Vaccine Sales Market Share by Countries (2015-2020)
Table 66. South America Typhoid Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Typhoid Vaccine Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Typhoid Vaccine Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Typhoid Vaccine Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Typhoid Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Typhoid Vaccine Revenue Market Share by Countries (2015-2020)
Table 72. Global Typhoid Vaccine Sales by Type (2015-2020) (K Units)
Table 73. Global Typhoid Vaccine Sales Share by Type (2015-2020)
Table 74. Global Typhoid Vaccine Revenue by Type (2015-2020) (USD Million)
Table 75. Global Typhoid Vaccine Revenue Share by Type (2015-2020)
Table 76. Global Typhoid Vaccine Sales by Application (2015-2020) (K Units)
Table 77. Global Typhoid Vaccine Sales Share by Application (2015-2020)
Table 78. Global Typhoid Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Typhoid Vaccine Market Share Forecast by Regions (2021-2025)
Table 80. Global Typhoid Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Typhoid Vaccine Market Share Forecast by Type (2021-2025)
Table 82. Global Typhoid Vaccine Sales Forecast by Application (2021-2025)
Table 83. Global Typhoid Vaccine Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Typhoid Vaccine Picture
Figure 2. Global Sales Market Share of Typhoid Vaccine by Type in 2019
Figure 3. Oral Type Picture
Figure 4. Injection Type Picture
Figure 5. Typhoid Vaccine Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Research & Academic Laboratories Picture
Figure 8. Pharmaceutical & Biotechnology Companies Picture
Figure 9. Others Picture
Figure 10. Global Typhoid Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Typhoid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Typhoid Vaccine Sales Market Share by Manufacturer in 2019
Figure 31. Global Typhoid Vaccine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Typhoid Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Typhoid Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Typhoid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Typhoid Vaccine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Typhoid Vaccine Revenue Market Share by Regions in 2018
Figure 39. North America Typhoid Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Europe Typhoid Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Typhoid Vaccine Sales and Growth Rate (2015-2020)
Figure 42. South America Typhoid Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Typhoid Vaccine Sales and Growth Rate (2015-2020)
Figure 44. North America Typhoid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Typhoid Vaccine Sales Market Share by Countries (2015-2020)
Figure 46. North America Typhoid Vaccine Sales Market Share by Countries in 2018
Figure 47. North America Typhoid Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Typhoid Vaccine Revenue Market Share by Countries in 2018
Figure 49. United States Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Typhoid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Typhoid Vaccine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Typhoid Vaccine Revenue Market Share by Countries in 2019
Figure 55. Germany Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Typhoid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Typhoid Vaccine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Typhoid Vaccine Revenue Market Share by Regions 2019
Figure 63. China Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Typhoid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Typhoid Vaccine Sales Market Share by Countries in 2019
Figure 70. South America Typhoid Vaccine Revenue Market Share by Countries in 2019
Figure 71. Brazil Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Typhoid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Typhoid Vaccine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Typhoid Vaccine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Typhoid Vaccine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Typhoid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Typhoid Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Typhoid Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Typhoid Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Typhoid Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Typhoid Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Typhoid Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Typhoid Vaccine Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel